Basit öğe kaydını göster

dc.contributor.authorKarakus, Nevin
dc.contributor.authorKara, Nurten
dc.contributor.authorUlusoy, Ali N.
dc.contributor.authorOzaslan, Cihangir
dc.contributor.authorTural, Sengul
dc.contributor.authorOkan, Ismail
dc.date.accessioned2020-06-21T13:45:33Z
dc.date.available2020-06-21T13:45:33Z
dc.date.issued2015
dc.identifier.issn2296-5270
dc.identifier.issn2296-5262
dc.identifier.urihttps://doi.org/10.1159/000438940
dc.identifier.urihttps://hdl.handle.net/20.500.12712/14113
dc.descriptionOzaslan, Cihangir/0000-0002-2611-4837en_US
dc.descriptionWOS: 000361090300002en_US
dc.descriptionPubMed: 26407154en_US
dc.description.abstractBackground: Polymorphisms of estrogen synthesis- and adiposity-related genes can contribute to the development of breast cancer. The purpose of the current study was to analyze the association between CYP17A1 T27C (rs743572) and LEP -2548G>A (rs7799039) gene polymorphisms and breast cancer. Material and Methods: 199 breast cancer patients and 197 healthy controls were included in the study. The CYP17A1 and LEP gene polymorphisms were determined using polymerase chain reaction-based restriction fragment length polymorphism analysis. Results: No statistically significant association was found between these polymorphisms and breast cancer risk among a Turkish population. However, stratified analysis of these polymorphisms in relation to different clinicopathological characteristics of breast cancer revealed an association between breast cancer diagnosis and the CYP17A1 T27C polymorphism (p = 0.024). Conclusion: Our study suggests no strong association between the CYP17A1 T27C and LEP -2548G>A polymorphisms and the incidence of breast cancer in Turkish women. The potential association between CYP17A1 T27C and the type of breast cancer deserves further consideration. (C) 2015 S. Karger GmbH, Freiburgen_US
dc.description.sponsorshipGaziosmanpasa UniversityGaziosmanpasa University [2013/17]en_US
dc.description.sponsorshipThis study was supported by Gaziosmanpasa University (project no. 2013/17).en_US
dc.language.isoengen_US
dc.publisherKargeren_US
dc.relation.isversionof10.1159/000438940en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectBreast canceren_US
dc.subjectLeptinen_US
dc.subjectCYP17A1en_US
dc.subjectGenetic susceptibilityen_US
dc.subjectPolymorphismen_US
dc.titleEvaluation of CYP17A1 and LEP Gene Polymorphisms in Breast Canceren_US
dc.typearticleen_US
dc.contributor.departmentOMÜen_US
dc.identifier.volume38en_US
dc.identifier.issue9en_US
dc.identifier.startpage418en_US
dc.identifier.endpage422en_US
dc.relation.journalOncology Research and Treatmenten_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster